@article{bd1b854b43e044af988e123d6cfaf3bc,
title = "CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel",
keywords = "ATP Binding Cassette Transporter, Subfamily B, ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics, Acute Coronary Syndrome/drug therapy, Aryl Hydrocarbon Hydroxylases/genetics, Clopidogrel, Cytochrome P-450 CYP2C19, Genetic Variation/drug effects, Humans, Platelet Aggregation Inhibitors/adverse effects, Precision Medicine, Ticlopidine/adverse effects",
author = "Peters, \{Bas J M\} and Harmsze, \{Ankie M\} and \{ten Berg\}, \{Jurri{\"e}n M\} and \{Maitland-van der Zee\}, Anke-Hilse and Tjoeng, \{Mathieu M\} and \{de Boer\}, Anthonius and Deneer, \{Vera H M\}",
year = "2011",
month = feb,
doi = "10.2217/pgs.10.211",
language = "English",
volume = "12",
pages = "141--4",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Taylor and Francis Ltd.",
number = "2",
}